ASX Announcements

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

DOCUMENT	RELEASED
Eurosets – 4 December 2023	4 Dec 2023
Appendix 3G – 22 November 2023	22 Nov 2023
Receives Marketing Approval For Rhythmic Infusion Pump – 21 November 2023	21 Nov 2023
AGM Results Of Meeting – 10 November 2023	10 Nov 2023
AGM Chairmans Address – 10 November 2023	10 Nov 2023
AGM Presentation – 10 November 2023	10 Nov 2023
Appendix 3B – 10 November 2023	10 Nov 2023
Net Tangible Asset Backing – 31 October 2023	31 Oct 2023
Appendix 4E and Annual Report – 30 June 2023	24 Oct 2023
BTC Shareholder Update – June 2023	24 Oct 2023
Appendix 4G	24 Oct 2023
Notice Of Annual General Meeting And Proxy Form – 9 October 2023	9 Oct 2023
BTC No Change In Bronchitol And Aridol License Agreement – 3 October 2023	3 Oct 2023
Net Tangible Asset Backing – 30 September 2023	30 Sep 2023
Exclusive Distribution Agreement With Micrel Medical Devices – 21 September 2023	21 Sep 2023
Acquires Neuro-Spinal Medical Products Business – 18 September 2023	18 Sep 2023
Form 603 – 12 September 2023	12 Sep 2023
Form 605 – 11 September 2023	11 Sep 2023
Form 604 – 11 September 2023	11 Sep 2023
Form 604 – 8 September 2023	8 Sep 2023
Appendix 2A – 7 September 2023	7 Sep 2023
Form 708 – 7 September 2023	7 Sep 2023
Appendix 3G – 4 September 2023	4 Sep 2023
Appendix 3H – 1 September 2023	1 Sep 2023
Appendix 3B – 1 September 2023	1 Sep 2023
Share Placement to Strategic Investors – 1 September 2023	1 Sep 2023
Net Tangible Asset Backing – 31 August 2023	31 Aug 2023
Appendix 4E and Annual Report – 30 June 2023	24 Aug 2023
BTC Shareholder Update – June 2023	24 Aug 2023
Appendix 4G	24 Aug 2023
Audit and Risk Committee Charter – 22 August 2023	22 Aug 2023
Net Tangible Asset Backing – 31 May 2023	14 Jun 2023
BTC_Appendix_3Z_Jonathan_Pilcher	2 Jun 2023
Avanos provides notice – acute pain infusion products in ANZ	17 Apr 2023
Net Tangible Asset Backing – March 2023	12 Apr 2023
Ceasing to be a substantial holder	10 Mar 2023
Net Tangible Assets – February 2023	2 Mar 2023
Half-Year Financial Report & Appendix 4D – 31 December 2022	16 Feb 2023
BTC Shareholder Update – February 2023	16 Feb 2023
Net Tangible Asset Backing – 31 January 2023	8 Feb 2023
Net Tangible Asset Backing – December 2022	23 Jan 2023

DOCUMENT	RELEASED
Net Tangible Asset Backing – November 2022	5 Dec 2022
2022 AGM Results of Meeting	29 Nov 2022
Annual General Meeting 2022 Presentation & Address	29 Nov 2022
Change in substantial holding	21 Nov 2022
Net Tangible Asset Backing – 31 October 2022	8 Nov 2022
Change in substantial holding	3 Nov 2022
Notice of Annual General Meeting and Proxy Form	28 Oct 2022
Net Tangible Asset Backing – November 2022	24 Oct 2022
Net Tangible Asset Backing – September 2022 update	11 Oct 2022
Appendix 3X	11 Oct 2022
Appendix 3X	11 Oct 2022
Appointment of Felicity McNeill & Brendan York as Directors	11 Oct 2022
Net Tangible Asset Backing – 30 September 2022	6 Oct 2022
Change of Director’s Interest Notice – Richard Treagus	15 Sep 2022
Net Tangible Asset Backing – 31 August 2022	8 Sep 2022
Change in substantial holding September	6 Sep 2022
Change in substantial holding	18 Aug 2022
BTC Shareholder Update – June 2022	17 Aug 2022
BTC secures distribution rights for Alteco LPS Adsorber	17 Aug 2022
Appendix 4G	16 Aug 2022
Appendix 4E Annual Report – 30 June 2022	16 Aug 2022
Net Tangible Asset Backing – 31 July 2022	8 Aug 2022
Net Tangible Asset Backing – June 2022	19 Jul 2022
Change in substantial holding	23 Jun 2022
Net Tangible Asset Backing – 31 May 2022	15 Jun 2022
Change in substantial holding	9 Jun 2022
Net Tangible Assets – 30 April 2022	10 May 2022
DOH confirms no change to Prostheses List benefits	5 May 2022
Department of Health proposes changes to Prostheses List	19 Apr 2022
Net Tangible Asset Backing – March 2022	7 Apr 2022
Net Tangible Asset Backing – February 2022	21 Mar 2022
Net Tangible Asset Backing – January 2022	28 Feb 2022
BTC Shareholder Update – February 2022	15 Feb 2022
Half-Year Financial Report & Appendix 4D – 31 December 2021	15 Feb 2022
Results of Extraordinary General Meeting 31 January 2022	31 Jan 2022
Net Tangible Asset Backing – 31 December 2021	27 Jan 2022

DOCUMENT	RELEASED
Notice of Extraordinary General Meeting and Proxy Form	31 Dec 2021
Net Tangible Asset Backing – 30 November 2021	8 Dec 2021
Annual General Meeting Presentation 2021	23 Nov 2021
BTC Chairman’s Address 2021	23 Nov 2021
Results of Annual General Meeting – 23 November 2021	23 Nov 2021
Change of Director’s Interest Notice – Richard Treagus	23 Nov 2021
Net Tangible Asset Backing – 31 October 2021	10 Nov 2021
Notice of Annual General Meeting and Proxy Form	22 Oct 2021
Notice in accordance with ASX listing rule 3.16	22 Oct 2021
Net Tangible Assets Backing – 30 September 2021	22 Oct 2021
BTC Shareholder Update – September 2021	3 Sep 2021
Appendix 4G	18 Aug 2021
BTC investment opportunity – Mannitol portfolio	5 Jul 2021
Proposed issue of securties	2 Jul 2021
BTC health $2.5m capital raise to acquire the distribution rights to Bronchitol and Aridol	2 Jul 2021
BTC health acquires exclusive distribution rights for Bronchitol and Aridol	30 Jun 2021
BTC secures exclusive distribution rights for NEOLA® from GPX Medical	22 Feb 2021

DOCUMENT	RELEASED
Results of Annual General Meeting 24 November 2020	24 Nov 2020
Chairman’s Address to Shareholders 2020	24 Nov 2020
Net Tangible Asset Backing – 31 October 2020	10 Nov 2020
Notice of Annual General Meeting and Proxy Form	22 Oct 2020
BTC Speciality Health receives ISO13485 certification	14 Oct 2020
Net Tangible Asset Backing – September 2020	5 Oct 2020
Net Tangible Asset Backing – August 2020	14 Sep 2020
Change in substantial holding	8 Sep 2020
30 June 2020 full-year result and business update	18 Aug 2020
Appendix 4G	18 Aug 2020
BTC healh completes sale of investment in Bio101 Group	31 Jul 2020
Change in substantial holding	14 Jul 2020
Net Tangible Asset Backing – 30 June 2020	10 Jul 2020
Change in substantial holding	3 Jul 2020
Net Tangible Asset backing – 31 May 2020	5 Jun 2020
Market update – elective surgery recommences	19 May 2020
Net Tangible Asset Backing – April 2020	13 May 2020
Net Tangible Asset Backing – March 2020	14 Apr 2020
COVID-19 market update	26 Mar 2020
Net Tangible Asset Backing – February 2020	16 Mar 2020
Change in substantial holding	6 Mar 2020
Change in substantial holding	6 Mar 2020
Appointment of Auditor	3 Mar 2020
31 December 2019 half-year result and business update	18 Feb 2020
Half Yearly Report and Accounts – 31 December 2019	18 Feb 2020
Net Tangible Asset Backing – January 2020	11 Feb 2020
Change in substantial holding	15 Jan 2020
Net Tangible Asset Backing – 31 December 2019	15 Jan 2020

DOCUMENT	RELEASED
Net Tangible Asset Backing – 30 November 2019	11 Dec 2019
Appendix 3B	3 Dec 2019
Appendix 3B	3 Dec 2019
Change of Director’s Interest Notice – Richard Treagus	3 Dec 2019
Appendix 3B	2 Dec 2019
Appendix 3B	2 Dec 2019
Appendix 3Z	27 Nov 2019
Results of Annual General Meeting 26 November 2019	26 Nov 2019
Chairman’s Address to Shareholders 2019	26 Nov 2019
Net Tangible Asset Backing – 31 October 2019	11 Nov 2019
Notice of Annual General Meeting/Proxy Form	25 Oct 2019
Net Tangible Asset Backing – 30 September 2019	3 Oct 2019
Appointment of CFO & Company Secretary	4 Sep 2019
Net Tangible Asset Backing – 31 August 2019	3 Sep 2019
Cleansing Notice	28 Aug 2019
Appendix 3B	28 Aug 2019
Appendix 4G	16 Aug 2019
Becoming a substantial holder – LHC Capital (Amendment)	14 Aug 2019
Becoming a substantial holder – LHC Capital	14 Aug 2019
Ceasing to be a substantial holder	14 Aug 2019
Net Tangible Asset Backing – 31 July 2019	9 Aug 2019
Summit Medical transfers ambIT products to Avanos Medical	7 Aug 2019
Change in substantial holding	6 Aug 2019
Appointment of Peter Mears as an adviser to BTC health	6 Aug 2019
Initial Director’s Interest Notice – Bruce Hewett	5 Aug 2019
Appointment of Bruce Hewett as a non-executive director	5 Aug 2019
Change of Director’s Interest Notice – Peter Jones	18 Jul 2019
Net Tangible Asset Backing – 30 June 2019	8 Jul 2019
Change in substantial holding	3 Jul 2019
Change of Director’s Interest Notice – Richard Treagus	3 Jul 2019
Appendix 3B & Cleansing Notice	3 Jul 2019
Change of Director’s Interest Notice – Peter Jones	3 Jul 2019
Change in substantial holding – Peter & Helen Jones	2 Jul 2019
Change in substantial holding	1 Jul 2019
Change of Director’s Interest Notice – Peter Jones	1 Jul 2019
Change of Director’s Interest Notice – Jonathan Pilcher	1 Jul 2019
Appendix 3B & Cleansing Notice	27 Jun 2019
Results of Extraordinary General Meeting 21 June 2019	21 Jun 2019
Chairman’s Address to Shareholders 2019	21 Jun 2019
Change of Director’s Interest Notice – Peter Jones	13 Jun 2019
Change of Director’s Interest Notice – Richard Treagus	13 Jun 2019
Appendix 3B & Cleansing Notice	13 Jun 2019
Change of Director’s Interest Notice – Peter Jones	12 Jun 2019
Share Purchase Plan Completion	12 Jun 2019
Change of Director’s Interest Notice – Peter Jones	11 Jun 2019
Net Tangible Asset Backing – May 2019	11 Jun 2019
Change of Director’s Interest Notice – Peter Jones	5 Jun 2019
Change of Director’s Interest Notice – Peter Jones	3 Jun 2019
Completion of acquisition of Hospital Infusion Business	31 May 2019
Becoming a substantial holder from SIG	28 May 2019
Change in substantial holding	28 May 2019
Change of Director’s Interest Notice – Peter Jones	28 May 2019
Change in substantial holding – Peter & Helen Jones	27 May 2019
Change in substantial holding – Richard Treagus	27 May 2019
Extension of Share Purchase Plan	27 May 2019
Change in substantial holding	24 May 2019
Cleansing Notice	23 May 2019
Appendix 3B	23 May 2019
Change of Director’s Interest Notice – Peter Jones	20 May 2019
Notice of Extraordinary General Meeting/Proxy Form	20 May 2019
Share Purchase Plan	15 May 2019
Change of Director’s Interest Notice – Peter Jones	15 May 2019
Completion of $8m private placement to fund acquisition	15 May 2019
BTC health to acquire Hospital Infusion Business	13 May 2019
Trading Halt	13 May 2019
Appendix 3B	6 May 2019
Net Tangible Asset Backing – 30 April 2019	1 May 2019
ChloraSolv CE Approval Granted	12 Apr 2019
Net Tangible Asset Backing – 31 March 2019	1 Apr 2019
Net Tangible Asset Backing – 28 February 2019	4 Mar 2019
Half Yearly Report and Accounts – 31 December 2018	18 Feb 2019
Net Tangible Asset Backing – 31 January 2019	11 Feb 2019
Net Tangible Asset Backing – 31 January 2019	11 Feb 2019
episil added to the TGA register	5 Feb 2019
Net Tangible Asset Backing – 31 December 2018	4 Jan 2019
Net Tangible Asset Backing – 31 December 2018	4 Jan 2019

DOCUMENT	RELEASED
Net Tangible Asset Backing – 30 November 2018	4 Dec 2018
Net Tangible Asset Backing – 30 November 2018	3 Dec 2018
Results of Annual General Meeting 28 November 2018	28 Nov 2018
Chairman’s Address to Shareholders 2018	28 Nov 2018
BioImpact licenses episil for Australia and New Zealand	25 Nov 2018
Net Tangible Asset Backing – 31 October 2018	5 Nov 2018
Notice of Annual General Meeting/Proxy Form	26 Oct 2018
Net Tangible Asset Backing – 30 September 2018	3 Oct 2018
Net Tangible Asset Backing – 31 August 2018	6 Sep 2018
Appendix 4G 30 June 2018	21 Aug 2018
Appendix 4E and Financial Report 30 June 2018	21 Aug 2018
Change in substantial holding	9 Aug 2018
Net Tangible Asset Backing – 31 July 2018	7 Aug 2018
Net Tangible Asset Backing – 30 June 2018	10 Jul 2018
Net Tangible Asset Backing – 31 May 2018	6 Jun 2018
Final Director’s Interest Notice – Bruce Hancox	31 May 2018
Non-executive director retirement	31 May 2018
Net Tangible Asset Backing – 30 April 2018	1 May 2018
Change in substantial holding – Richard Treagus	20 Apr 2018
Change of Director’s Interest Notice – Richard Treagus	20 Apr 2018
Change of Director’s Interest Notice – Peter Jones	20 Apr 2018
Ceasing to be a substantial holder	20 Apr 2018
Final Director’s Interest Notice – Jennifer Herz	20 Apr 2018
Appendix 3B	20 Apr 2018
Results of Extraordinary General Meeting 17 April 2018	17 Apr 2018
Net Tangible Asset Backing – 31 March 2018	3 Apr 2018
Notice of Extraordinary General Meeting/Proxy Form	16 Mar 2018
Net Tangible Asset Backing – 28 February 2018	8 Mar 2018
Half Yearly Report and Accounts – 31 December 2017	26 Feb 2018
Change in substantial holding	7 Feb 2018
Net Tangible Asset Backing – 31 January 2018	5 Feb 2018
Perisolv dental product added to the ARTG	2 Feb 2018
Proposed Divestment of Biointelect	22 Jan 2018
Carisolv dental product added to the ARTG	8 Jan 2018
Net Tangible Asset Backing – 31 December 2017	3 Jan 2018

ASX Announcements

Investors Centre

Shareholder Information

Investments

Financial Reports

Corporate Governance

ASX Announcements

Contact us

Contact

Company

Investor Centre

DOCUMENT	RELEASED
Notice in accordance with Listing Rule 3.16	15 Dec 2016
Net Tangible Asset Backing – 30 November 16	6 Dec 2016
Results of Annual General Meeting 29 November 2016	29 Nov 2016
Chairman’s Address to Shareholders 2016 AGM	29 Nov 2016
Strategic Alliance with Industry Expert in San Diego, USA	21 Nov 2016
Net Tangible Asset Backing – 31 October 2016-BTC.AX	1 Nov 2016
Notice of Annual General Meeting/Proxy Form-BTC.AX	27 Oct 2016
Notice of Annual General Meeting/Proxy Form-BTC.AX	27 Oct 2016
Change of Director’s Interest Notice – Jennifer Herz-BTC.AX	27 Oct 2016
Change of Director’s Interest Notice – Richard Treagus-BTC.AX	27 Oct 2016
Appendix 4G 30 June 2016-BTC.AX	25 Oct 2016
Net Tangible Asset Backing – 30 September 2016-BTC.AX	11 Oct 2016
Financial Statements and Directors Report – 30 June 2016-BTC.AX	7 Sep 2016
Net Tangible Asset Backing – 31 August 2016-BTC.AX	1 Sep 2016
Appendix 4E – 30 June 2016-BTC.AX	30 Aug 2016
Net Tangible Asset Backing – 31 July 2016-BTC.AX	12 Aug 2016
Biotech Capital invests in bio101Group-BTC.AX	4 Jul 2016
Net Tangible Asset Backing – 30 June 2016-BTC.AX	4 Jul 2016
Net Tangible Asset Backing – 31 May 2016-BTC.AX	1 Jun 2016
Net Tangible Asset Backing – 30 April 2016-BTC.AX	2 May 2016
Ceasing to be a substantial holder-BTC.AX	21 Apr 2016
Change in substantial holding-BTC.AX	6 Apr 2016
Change in substantial holding-BTC.AX	6 Apr 2016
Change in substantial holding – Richard Treagus-BTC.AX	5 Apr 2016
Change in substantial holding – Peter Jones-BTC.AX	5 Apr 2016
Change of Director’s Interest Notice – Peter Jones-BTC.AX	5 Apr 2016
Becoming a substantial holder – Windarri Investments-BTC.AX	5 Apr 2016
Initial Director’s Interest Notice – Jennifer Herz-BTC.AX	5 Apr 2016
Appendix 3B-BTC.AX	5 Apr 2016
Strategic Acquisition of Biointelect-BTC.AX	4 Apr 2016
Net Tangible Asset Backing – 31 March 2016	1 Apr 2016
Becoming a substantial holder	16 Mar 2016
Net Tangible Asset Backing – 29 February 2016	1 Mar 2016
Half Yearly Report and Accounts	24 Feb 2016
Share trading policy	23 Feb 2016
Net Tangible Asset Backing 31 January 2016	1 Feb 2016
Net Tangible Asset Backing 31 December 2015	4 Jan 2016

DOCUMENT	RELEASED
Net Tangible Asset Backing 31 May 2014	2 Jun 2014
Net Tangible Asset Backing 30 April 2014	1 May 2014
Update of Share Registry Address April 2014	22 Apr 2014
Net Tangible Asset Backing 31 March 2014	1 Apr 2014
Ceasing to be a substantial holder	21 Mar 2014
Becoming a substantial holder – DDC	21 Mar 2014
Response to ASX price query	20 Mar 2014
Becoming a substantial holder	5 Mar 2014
Net Tangible Asset Backing 28 February 2014	4 Mar 2014
Half Yearly Report and Accounts 31 December 2013	21 Feb 2014
Net Tangible Asset Backing 31 January 2014	3 Feb 2014
Net Tangible Asset Backing 31 December 2013	2 Jan 2014

DOCUMENT	RELEASED
Net Tangible Asset Backing 30 November 2013	3 Dec 2013
Results of Annual General Meeting 19 November 2013	19 Nov 2013
Chairman’s Address to Shareholders 2013 AGM	19 Nov 2013
Change in substantial holding	8 Nov 2013
Change in substantial holding	1 Nov 2013
Net Tangible Asset Backing 31 October 2013	1 Nov 2013
Change in substantial holding	22 Oct 2013
Proxy Form 2013	15 Oct 2013
Notice of Annual General Meeting 2013	15 Oct 2013
Net Tangible Asset Backing 30 September 2013	1 Oct 2013
Net Tangible Asset Backing 31 August 2013	2 Sep 2013
Financial Report 30 June 2013	20 Aug 2013
Appendix 4E 30 June 2013	20 Aug 2013
Becoming a substantial holder	6 Aug 2013
Ceasing to be a substantial holder	2 Aug 2013
Net Tangible Asset Backing 31 July 2013	2 Aug 2013
Change in substantial holding	25 Jul 2013
Change in substantial holding	12 Jul 2013
Net Tangible Asset Backing 30 june 2013	1 Jul 2013
Net Tangible Asset Backing 31 May 2013	3 Jun 2013
Net Tangible Asset Backing 30 April 2013	1 May 2013
Response to ASX Query	11 Apr 2013
Net Tangible Asset Backing 28 February 2013	1 Mar 2013
Half Yearly Report and Accounts 31 December 2012	20 Feb 2013
Net Tangible Asset Backing 31 January 2013	1 Feb 2013
Net Tangible Asset Backing 31 December 2012	2 Jan 2013

DOCUMENT	RELEASED
Change of Director’s Interest Notice E W Taylor	19 Dec 2012
Net Tangible Asset Backing 30 November 2012	3 Dec 2012
Final Director’s Interest Notice Kathryn Greiner	28 Nov 2012
Initial Director’s Interest Notice Edward Taylor	28 Nov 2012
Results of AGM 20 November 2012	21 Nov 2012
Chairman’s Address to Shareholders AGM 20 November 2012	20 Nov 2012
Net Tangible Asset Backing 31 October 2012	1 Nov 2012
Share Sale Facility	26 Oct 2012
Proxy Form AGM 20 November 2012	16 Oct 2012
Notice of Annual General Meeting 20 November 2012	16 Oct 2012
Shareholder Update October 2012	16 Oct 2012
Net Tangible Asset Backing 30 September 2012	2 Oct 2012
Shareholder Update	25 Sep 2012
Net Tangible Asset Backing 31 August 2012	3 Sep 2012
Preliminary Final Report Financial Report	31 Aug 2012
Preliminary Final Report Appendix 4E	31 Aug 2012
Net Tangible Asset Backing 31 July 2012	1 Aug 2012
Net Tangible Asset Backing 30 June 2012	2 Jul 2012
Ceasing to be a substantial holder from BTC	21 Jun 2012
Net Tangible Asset Backing 31 May 2012	4 Jun 2012
Net Tangible Asset Backing 30 April 2012	1 May 2012
Net Tangible Asset Backing 31 March 2012	3 Apr 2012
Net Tangible Asset Backing 29 February 2012	6 Mar 2012
Half Yearly Report and Accounts 31 December 2011	20 Feb 2012
Net Tangible Asset Backing 31 January 2012	1 Feb 2012
Net Tangible Asset Backing 31 December 2011	4 Jan 2012

DOCUMENT	RELEASED
Securities Trading Policy December 2010	30 Dec 2010
Net Tangible Asset Backing 30 November 2010	2 Dec 2010
Results of Annual General Meeting 17 November 2010	18 Nov 2010
Chairman’s Address to Shareholders AGM 17 November 2010	17 Nov 2010
Net Tangible Asset Backing 31 October 2010	1 Nov 2010
Results of Shareholders Meeting 18 October 2010	18 Oct 2010
Annual General Meeting Proxy Form 17 November 2010	5 Oct 2010
Notice of Annual General Meeting 17 November 2010	5 Oct 2010
Net Tangible Asset Backing 30 September 2010	4 Oct 2010
Change of Auditor	29 Sep 2010
Revised Notice of Extraordinary General Meeting	14 Sep 2010
Revised Notice of EGM Announcement	14 Sep 2010
Proxy Form 18 October 2010	13 Sep 2010
Notice of Extraordinary General Meeting 18 October 2010	13 Sep 2010
2 cent per Ordinary Share Dividend Details	2 Sep 2010
Net Tangible Asset Backing 31 August 2010	1 Sep 2010
Financial Report 30 June 2010	31 Aug 2010
Preliminary Final Report 30 June 2010	31 Aug 2010
Director Resignation Prof. Antony Basten	12 Aug 2010
Change in Investment Strategy and Restructuring	12 Aug 2010
Net Tangible Asset Backing 31 July 2010	2 Aug 2010
Cancelled share notice pursuant to on market buyback	8 Jul 2010
Net Tangible Asset Backing	2 Jul 2010
Change in substantial holding	21 Jun 2010
Daily share buy-back notice – Appendix 3E	16 Jun 2010
Daily share buy-back notice – Appendix 3E	16 Jun 2010
Cancelled share notice pursuant to on market buyback	15 Jun 2010
Daily share buy-back notice – Appendix 3E	10 Jun 2010
Daily share buy-back notice – Appendix 3E	9 Jun 2010
Daily share buy-back notice – Appendix 3E	9 Jun 2010
Daily share buy-back notice – Appendix 3E	8 Jun 2010
Daily share buy-back notice – Appendix 3E	7 Jun 2010
Daily share buy-back notice – Appendix 3E	3 Jun 2010
Net Tangible Asset Backing 31 May 2010	3 Jun 2010
Daily share buy-back notice – Appendix 3E	1 Jun 2010
Daily share buy-back notice – Appendix 3E	31 May 2010
Daily share buy-back notice – Appendix 3E	28 May 2010
Daily share buy-back notice – Appendix 3E	26 May 2010
Daily share buy-back notice – Appendix 3E	25 May 2010
Daily share buy-back notice – Appendix 3E	24 May 2010
Daily share buy-back notice – Appendix 3E	21 May 2010
Daily share buy-back notice – Appendix 3E	21 May 2010
Daily share buy-back notice – Appendix 3E	20 May 2010
Daily share buy-back notice – Appendix 3E	18 May 2010
Cancelled share notice pursuant to on market buyback	17 May 2010
Daily share buy-back notice – Appendix 3E	17 May 2010
Daily share buy-back notice – Appendix 3E	14 May 2010
Daily share buy-back notice – Appendix 3E	11 May 2010
Daily share buy-back notice – Appendix 3E	10 May 2010
Daily share buy-back notice – Appendix 3E	10 May 2010
Daily share buy-back notice – Appendix 3E	6 May 2010
Daily share buy-back notice – Appendix 3E	5 May 2010
Daily share buy-back notice – Appendix 3E	4 May 2010
Net Tangible Asset Backing 30 April 2010	4 May 2010
Daily share buy-back notice – Appendix 3E	30 Apr 2010
Daily share buy-back notice – Appendix 3E	29 Apr 2010
Daily share buy-back notice – Appendix 3E	28 Apr 2010
Daily share buy-back notice – Appendix 3E	27 Apr 2010
Daily share buy-back notice – Appendix 3E	23 Apr 2010
Daily share buy-back notice – Appendix 3E	22 Apr 2010
Cancelled share notice pursuant to on market buyback	21 Apr 2010
Daily share buy-back notice – Appendix 3E	21 Apr 2010
Daily share buy-back notice – Appendix 3E	20 Apr 2010
Daily share buy-back notice – Appendix 3E	19 Apr 2010
Daily share buy-back notice – Appendix 3E	19 Apr 2010
Daily share buy-back notice – Appendix 3E	14 Apr 2010
Daily share buy-back notice – Appendix 3E	14 Apr 2010
Daily share buy-back notice – Appendix 3E	12 Apr 2010
Daily share buy-back notice – Appendix 3E	7 Apr 2010
Net Tangible Asset Backing 31 March 2010	1 Apr 2010
Daily share buy-back notice – Appendix 3E	31 Mar 2010
Daily share buy-back notice – Appendix 3E	30 Mar 2010
Daily share buy-back notice – Appendix 3E	26 Mar 2010
Daily share buy-back notice – Appendix 3E	25 Mar 2010
Daily share buy-back notice – Appendix 3E	24 Mar 2010
Daily share buy-back notice – Appendix 3E	24 Mar 2010
Daily share buy-back notice – Appendix 3E	22 Mar 2010
Daily share buy-back notice – Appendix 3E	19 Mar 2010
Daily share buy-back notice – Appendix 3E	17 Mar 2010
Daily share buy-back notice – Appendix 3E	16 Mar 2010
Daily share buy-back notice – Appendix 3E	15 Mar 2010
Daily share buy-back notice – Appendix 3E	9 Mar 2010
Net Tangible Asset Backing 28 February 2010	3 Mar 2010
Daily share buy-back notice – Appendix 3E	2 Mar 2010
Half Yearly Report and Accounts	18 Feb 2010
Appendix 4D	18 Feb 2010
Half Yearly Report	18 Feb 2010
Cancelled share notice pursuant to on market buyback	9 Feb 2010
Daily share buy-back notice – Appendix 3E	4 Feb 2010
Daily share buy-back notice – Appendix 3E	3 Feb 2010
Daily share buy-back notice – Appendix 3E	3 Feb 2010
Net Tangible Asset Backing 31 January 2010	2 Feb 2010
Daily share buy-back notice – Appendix 3E	2 Feb 2010
Daily share buy-back notice – Appendix 3E	29 Jan 2010
Daily share buy-back notice – Appendix 3E	28 Jan 2010
Daily share buy-back notice – Appendix 3E	27 Jan 2010
Net Tangible Asset Backing 31 December 2009	25 Jan 2010
Daily share buy-back notice – Appendix 3E	25 Jan 2010
Daily share buy-back notice – Appendix 3E	21 Jan 2010
Daily share buy-back notice – Appendix 3E	21 Jan 2010
Daily share buy-back notice – Appendix 3E	15 Jan 2010
Daily share buy-back notice – Appendix 3E	12 Jan 2010
Daily share buy-back notice – Appendix 3E	11 Jan 2010
Cancelled share notice pursuant to on market buyback	11 Jan 2010
Daily share buy-back notice – Appendix 3E	8 Jan 2010
Daily share buy-back notice – Appendix 3E	7 Jan 2010
Daily share buy-back notice – Appendix 3E	6 Jan 2010

DOCUMENT	RELEASED
Change in substantial holding from BTC	5 Dec 2008
Net Tangible Asset Backing 30 November 2008	4 Dec 2008
Announcement of buy-back – Appendix 3C	24 Nov 2008
Final Director’s Interest Notice – Lisa McIntyre	21 Nov 2008
2008 AGM – Chairman’s Address to Shareholders	20 Nov 2008
2008 AGM – Results of Meeting	20 Nov 2008
Director Resignation – Dr Lisa McIntyre	20 Nov 2008